Veselka J - Search Results

1

Long-term clinical outcome after alcohol septal ablation for obstructive hypertrophic cardiomyopathy: results from the Euro-ASA registry.

Veselka J, Jensen MK, Liebregts M, Januska J, Krejci J, Bartel T, Dabrowski M, Hansen PR, Almaas VM, Seggewiss H, Horstkotte D, Tomasov P, Adlova R, Bundgaard H, Steggerda R, Ten Berg J, Faber L. Veselka J, et al. Eur Heart J. 2016 May 14;37(19):1517-23. doi: 10.1093/eurheartj/ehv693. Epub 2016 Jan 7. Eur Heart J. 2016. PMID: 26746632

2

Early remodelling of left ventricle and improvement of myocardial performance in patients after percutaneous transluminal septal myocardial ablation for hypertrophic obstructive cardiomyopathy.

Veselka J, Honek T. Veselka J, et al. Int J Cardiol. 2003 Mar;88(1):27-32. doi: 10.1016/s0167-5273(02)00381-9. Int J Cardiol. 2003. PMID: 12659981 Clinical Trial.

3

The biphasic course of changes of left ventricular outflow gradient after alcohol septal ablation for hypertrophic obstructive cardiomyopathy.

Veselka J, Duchonová R, Procházková S, Homolová I, Pálenícková J, Zemánek D, Pernisová Z, Tesar D. Veselka J, et al. Kardiol Pol. 2004 Feb;60(2):133-6; discussion 137. Kardiol Pol. 2004. PMID: 15116158

4

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome.

Veselka J, Procházková S, Duchonová R, Bolomová-Homolová I, Pálenícková J, Tesar D, Cervinka P, Honek T. Veselka J, et al. Catheter Cardiovasc Interv. 2004 Oct;63(2):231-5. doi: 10.1002/ccd.20176. Catheter Cardiovasc Interv. 2004. PMID: 15390343 Clinical Trial.

5

Effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy on Doppler Tei index: a midterm follow-up.

Veselka J, Procházková S, Bolomová-Homolová I, Duchonová R, Tesar D. Veselka J, et al. Echocardiography. 2005 Feb;22(2):105-9. doi: 10.1111/j.0742-2822.2005.03148.x. Echocardiography. 2005. PMID: 15693775

6

Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes.

Veselka J, Duchonová R, Procházková S, Pálenícková J, Sorajja P, Tesar D. Veselka J, et al. Am J Cardiol. 2005 Mar 1;95(5):675-8. doi: 10.1016/j.amjcard.2004.10.050. Am J Cardiol. 2005. PMID: 15721120 Clinical Trial.

7

Veselka J, Duchonová R, Pálenícková J, Zemánek D, Sváb P, Hájek P, Maly M, Blásko P, Tesar D, Cervinka P. Veselka J, et al. Circ J. 2006 Jul;70(7):880-4. doi: 10.1253/circj.70.880. Circ J. 2006. PMID: 16799242 Free article.

8

Impact of ethanol dosing on the long-term outcome of alcohol septal ablation for obstructive hypertrophic cardiomyopathy: a single-center prospective, and randomized study.

Veselka J, Duchonová R, Páleníckova J, Zemánek D, Tiserová M, Linhartová K, Cervinka P. Veselka J, et al. Circ J. 2006 Dec;70(12):1550-2. doi: 10.1253/circj.70.1550. Circ J. 2006. PMID: 17127797 Free article. Clinical Trial.

9

Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a review of the literature.

Veselka J. Veselka J. Med Sci Monit. 2007 Apr;13(4):RA62-8. Med Sci Monit. 2007. PMID: 17392660 Review.

10

Left ventricular pseudoaneurysm as a late complication of mitral annuloplasty.

Linhartová K, Veselka J, Adla T. Linhartová K, et al. Among authors: veselka j. Eur Heart J. 2007 Oct;28(19):2360. doi: 10.1093/eurheartj/ehm120. Epub 2007 May 7. Eur Heart J. 2007. PMID: 17485483 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

255 results

Search Page

Filters